August 2019

Volume 85SupplementS1-S38
Efficacy, Immunogenicity, and Safety Evaluation of an MF59 Adjuvanted Trivalent Influenza Virus Vaccine Compared to Non-adjuvanted Influenza: A Comprehensive Review in Older Adults and Children
Open Access

Editorial Board

Full length article

Advertisement